Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Tidepool and Abbott’s new data integration partnership will simplify data sharing by automating data upload to Tidepool for patients wearing FreeStyle Libre sensors, and create more efficient ...

IRVINE, CA / ACCESSWIRE / October 30, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Tidepool collaborates with Abbott for seamless data integration with its FreeStyle Libre portfolio in the U.S., expanding patient choice and streamlining diabetes care workflows. Tidepool ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic stream of data from patients using Abbott’s FreeStyle Libre ...

Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...